Clinical Drug Investigation

SCI期刊
Clinical Drug Investigation
中文名称:
临床药物调查
期刊缩写:
Clin. Drug Invest.
影响因子:
2.9
ISSN:
print: 1173-2563
on-line: 1179-1918
研究领域:
医学-药学
创刊年份:
1989年
h-index:
53
自引率:
3.10%
Gold OA文章占比:
44.96%
原创研究文献占比:
75.51%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes: -Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs. -Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice. -Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed. -Studies focusing on the application of drug delivery technology in healthcare. -Short communications and case study reports that meet the above criteria will also be considered. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
5.90.6800.798
学科
排名
百分位
大类:Medicine
小类:Pharmacology (medical)
81 / 272
70%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
3区 医学
3区 药学 PHARMACOLOGY & PHARMACY
WOS期刊分区
学科分类
Q2PHARMACOLOGY & PHARMACY
历年影响因子
2015年1.8060
2016年1.8530
2017年1.9180
2018年2.1580
2019年2.2670
2020年2.8590
2021年3.5800
2022年3.2000
2023年2.9000
历年发表
2012年147
2013年141
2014年97
2015年107
2016年120
2017年122
2018年114
2019年141
2020年111
2021年116
2022年108
投稿信息
出版周期:
Monthly
出版语言:
English
出版国家(地区):
NEW ZEALAND
初审时长:
9 days
审稿时长:
6-12 weeks
出版商:
Springer International Publishing
编辑部地址:
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311

Clinical Drug Investigation - 最新文献

Diagnosis and Management of Drug-Induced Interstitial Lung Disease in the context of Anti-Cancer Therapy: a Multidisciplinary Viewpoint by Portuguese Experts.

Pub Date : 2024-11-05 DOI: 10.1007/s40261-024-01400-z Mário Fontes E Sousa, Sérgio Campainha, Inês Dias Marques, Rui Dinis, João Rodrigues Inácio, João João Mendes, Rita Luís, Ana Magalhães Ferreira, Ricardo Racha-Pacheco, Rui Rolo, Gabriela Sousa, Paulo Cortes

Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese Volunteers.

Pub Date : 2024-11-04 DOI: 10.1007/s40261-024-01402-x Mikael Sunnåker, Chandrali Bhattacharya, Karin Nelander, Malin Aurell, Maria Heijer, Anna Collén, David Han, Julie Holden, Monika Trebski, Pavlo Garkaviy, Hans Ericsson

Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus.

Pub Date : 2024-11-03 DOI: 10.1007/s40261-024-01405-8 Lisbet Westergaard, Lene Alifrangis, Stephen T Buckley, Hans Veit Coester, Thomas Klitgaard, Niels R Kristensen, Erica Nishimura, Lea Nørgreen, Thaís M P Rocha, Dorte B Steensgaard, Andreas Vegge, Leona Plum-Mörschel
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信